PTC Therapeutics (PTCT)
(Delayed Data from NSDQ)
$31.73 USD
+0.80 (2.59%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $31.74 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -1.01 |
EPS Last Quarter | -1.20 |
Last EPS Surprise | 0.83% |
ABR | 2.62 |
Earnings ESP
|
11.63% |
---|---|
Current Year | -4.90 |
Next Year | -3.35 |
EPS (TTM) | -5.86 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 188.37M | 175.29M | 768.86M | 787.68M |
# of Estimates | 4 | 4 | 5 | 5 |
High Estimate | 213.59M | 211.14M | 868.20M | 849.00M |
Low Estimate | 156.20M | 145.00M | 669.10M | 663.10M |
Year ago Sales | 213.81M | 196.58M | 937.82M | 768.86M |
Year over Year Growth Est. | -11.90% | -10.83% | -18.02% | 2.45% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.01 | -1.38 | -4.90 | -3.35 |
# of Estimates | 7 | 5 | 8 | 7 |
Most Recent Consensus | -0.73 | -1.47 | -4.72 | -4.60 |
High Estimate | -0.73 | -1.11 | -4.51 | -0.74 |
Low Estimate | -1.13 | -1.68 | -5.70 | -5.30 |
Year ago EPS | -2.66 | -1.76 | -3.62 | -4.90 |
Year over Year Growth Est. | 62.03% | 21.59% | -35.36% | 31.62% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 2 |
Up Last 60 Days | 3 | 3 | 4 | 4 |
Down Last 7 Days | 1 | 0 | 1 | 0 |
Down Last 30 Days | 2 | 1 | 3 | 2 |
Down Last 60 Days | 2 | 1 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.01 | -1.38 | -4.90 | -3.35 |
7 Days Ago | -1.01 | -1.38 | -4.88 | -3.35 |
30 Days Ago | -1.00 | -1.36 | -4.84 | -3.43 |
60 Days Ago | -1.23 | -1.69 | -5.36 | -4.62 |
90 Days Ago | -1.40 | -1.72 | -5.95 | -5.36 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.89 | -1.47 | -4.75 | -3.97 |
Zacks Consensus Estimate | -1.01 | -1.38 | -4.90 | -3.35 |
Earnings ESP | 11.63% | -6.68% | 3.06% | -18.61% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.20 | -0.24 | -1.76 | -2.66 | NA |
Estimate | -1.21 | 0.29 | -0.85 | -1.58 | NA |
Difference | 0.01 | -0.53 | -0.91 | -1.08 | -0.63 |
Surprise | 0.83% | -182.76% | -107.06% | -68.35% | -89.34% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more